Health Care Information and Resources

Elderly get fewer antipsychotics after FDA warning

An official warning about newer antipsychotics in demented elderly people appears to have deterred some doctors from prescribing the drugs, a new U.S. study shows. The so-called black box warning was issued by the Food and Drug Administration in 2005 after studies found elderly people on newer antipsychotics such as Janssen’s Risperdal and AstraZeneca’s Seroquel [...]

Continue reading...

Drugmakers, academics join up on mental illness

Nine major pharmaceutical companies have agreed to pool data on drug trials with academic institutions in an effort to improve ways of developing of new prescription medicines to treat psychiatric disorders such as schizophrenia. The collaboration, which involves Pfizer, AstraZeneca, Eli Lilly and Roche among others, will bring together data on 67 trials on 11 [...]

Continue reading...

Atypical Antipsychotics Linked to Blood Clot Risk in Study

People taking newer types of antipsychotic drugs, like Seroquel, may be at increased risk for developing a serious blood clot called a venous thromboembolism, British researchers say. Although developed to treat psychiatric illnesses, these drugs are also prescribed for other conditions such as nausea, vomiting and vertigo, potentially putting many people at risk, the researchers [...]

Continue reading...